- Windecker S, Meyer BJ, Meier B. On behalf of the working group. Cardiac interventional procedures performed in Europe during a four-year observation period from 1992 to 1995. 50A.
- Lefevre T, Morice MC, Karrillon G, et al. Coronary stenting in acute myocardial infarction with cardiogenic shock. 95A.
- Ishihara M, Sato H, Tateishi H, et al. Coronary angioplasty improves long-term survival after acute myocardial infarction. 232A.
- Griffin J, Brodie B, Morice MC, et al. Incidence and predictors of angiographic restenosis and reocclusion after primary infarct stenting--core lab analysis from the PAMI Stent Pilot Study. 210A.
- Rosenschein U, Hertz I, Tenenbaum-Koren E, et al. Coronary ultrasound thrombolysis in acute myocardial infarction: Results from the ACUTE Study. 192A.
- Nakagawa Y, Matsuo S, Tamura T. Angio-Jet thrombectomy catheter for acute myocardial infarction. 236A.
- Yokoi H, Kimura T, Hamasaki N, et al. Coronary stent restenosis; comparison of six different types of stent. 313A.
- Simes PA, Golf S, Myreng Y, et al. Sustained benefit of stenting in chronic occlusions: Long-term follow-up of the SICCO Study. 273A.
- Deutsch E, Martin JL, Fischman DL, et al. For the STRESS III Investigators. The late benefit of coronary stenting in small vessels is reduced in diabetic patients. 275A.
- Waksman R, Mehran R, Saucedo JF, et al. Balloons PTCA is equivalent to stents in patients with small coronaries: A comparative retrospective matching study. 275A.
- Kobayashi Y, DeGregorio J, Reimers B, et al. The length of the stented segment is an independent predictor of restenosis. 366A.
- Ishiwata S, Chronos NAF, Lin G, Narshall JJ, King III SB. Tranilast inhibits neointimal formation in balloon-injured and stented pig coronary arteries, and decreases negative remodeling after balloon injury. 144A.
- Nakamura T, Tsuchikane E, Sumitsuji S, Awata N, Kobayashi T. Impact of cilostazol on neointimal proliferation following Palmaz-Schatz stent implantation: A prospective randomized trial. 404A.
- DiDonato D, Di Roma A, Iacoboni C, Addonisio L, Dagianti A, Fedele F. Tumor Necrosis Factor Alpha blood levels as a potential marker of stenosis in patients undergoing percutaneous transluminal angioplasty. 102A.
- Baumgart D, Mohlenkamp S, Haude M, et al. Increased calcium content at the target lesion site as identified by electron beam computed tomography predisposes to higher restenosis rates following coronary interventions. 209A.
- Mahdi NA, Leon M, Mikulic M, et al. PTCA, Directional and rotational atherectomy in the management of Palmaz-Schatz instent restenosis. 275A.
- Koster R, Hamm CW, Terres W, et al. Long term results of laser angioplasty for in-stent restenosis. 141A.
- Waksman R, Condado JA, Saucedo JF, Lanski A, Popma JJ. Intracoronary radiation post PTCA prevents late arterial constriction: A QCA analysis. 222A.
- Moses JW, Ellis SG, Bailey SR, et al. For the IRIS Investigators. Short-term (1 month) results of the dose response IRIS feasibility study of a Beta particle emitting radioisotope stent. 350A.
- Waksman R, Chan RC, Vodovotz Y, Bass BG, Apple MG. Radioactive 133-Xenon gas-filled angioplasty balloon: A novel intracoronary radiation system to prevent restenosis. 356A.
- Ellis S, Nobuyoshi H, Tamai H, Plokker T, Park SJ, Suzuki T. Correlates of cardiac death early after hospital discharge in patients who have undergone percutaneous treatment of unprotected left main stenoses--what are the lessons? 214A.
- Park SJ, Macaya, Kimura T, Teirstein PS, Elllis SG. Prior to unprotected left main stenting--what is the benefit? A preliminary report. 18A.
- DeGregorio J, Finci L, Kobayashi Y, et al. Results of coronary stenting in patients aged 75years or older. 78A.
- Lucore CL, Trak RV, Mishkel GJ, et al. Outcomes and economics associated with use of abciximab in patients ≫70 years undergoing coronary interventions. 445A.
- Motwani JG, Kottke-Marchant K, Whitlow PL, Ellis SG, Topol EJ. Heparin-induced thrombocytopenia syndrome complicating percutaneous coronary intervention. 457A.
- Berger PB, Grill DE, Melby SJ, Bell MR, Holmes DR. Can ticlopidine be safely discontinued two weeks after coronary stent placement? 458A.
- Sharma SK, Kini A, Dangas G, et al. Stenting with abciximab (ReoPro) decreases target lesion revascularization. 237A.
- Braden GA, Love WM, Applegate RJ, Young TM, Sane DC. Abciximab decreases the incidence and magnitude of non-Q wave myocardial infarction associated with rotational atherectomy. 237A-238A.
- Tcheng JE, Kereiakes DJ, George BS, et al. For the R-3 investigators. Safety of readministration of abciximab; interim results of the ReoPro read-ministration registry. 55A.
- Seggewiss H, Faber L, Gleichman U, Strick S, Ziemssen P. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Clinical and noninvasive follow-up results. 182A.
International Journal of Cardiovascular Interventions
Volume 1, 1998 - Issue 1